CancerDrs

Breast Cancer clinical trials in Montana

9 actively recruiting breast cancer trials at 9 sites across Montana.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Network

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medicat…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT05929768
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Saint Vincent Frontier Cancer Center — Billings, Montana
  • Bozeman Health Deaconess Hospital — Bozeman, Montana
  • Saint James Community Hospital and Cancer Treatment Center — Butte, Montana
Phase 3 Recruiting Academic/Other

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

This phase III trial compares the effect of continuation of treatment with pembrolizumab (usual approach) to observation only at preventing cancer from coming back in patients with early-stage triple-negative breast cancer (TNBC) who achie…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05812807
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Bozeman Health Deaconess Hospital — Bozeman, Montana
  • Benefis Sletten Cancer Institute — Great Falls, Montana
  • Logan Health Medical Center — Kalispell, Montana
Phase 3 Recruiting Network

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are bei…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT03418961
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Bozeman Deaconess Hospital — Bozeman, Montana
  • Benefis Healthcare- Sletten Cancer Institute — Great Falls, Montana
  • Great Falls Clinic — Great Falls, Montana
Phase 3 Recruiting NIH

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

This phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high anatomic stage breast cancer with low risk of the cancer ret…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT07391774
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Bozeman Health Deaconess Hospital — Bozeman, Montana
  • Benefis Sletten Cancer Institute — Great Falls, Montana
  • Logan Health Medical Center — Kalispell, Montana
Phase 2 Recruiting Industry

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

The Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter study evaluating the efficacy, safety, and tolerability of evorpacept in combination with trastuzumab and chemotherapy in participants with HER2-positive metastatic br…

Sponsor: ALX Oncology Inc.
NCT ID: NCT07007559
Sites in Montana:
  • St. Vincent Regional Hospital - Cancer Centers of Montana — Billings, Montana
Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Bozeman Health Deaconess Hospital — Bozeman, Montana
  • Benefis Sletten Cancer Institute — Great Falls, Montana
  • Great Falls Clinic — Great Falls, Montana
Recruiting Academic/Other

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …

Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Montana Cancer Consortium NCORP — Billings, Montana
  • Bozeman Health Deaconess Hospital — Bozeman, Montana
  • Benefis Sletten Cancer Institute — Great Falls, Montana
Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in Montana:
  • Massive Bio SYNERGY-AI site — Billings, Montana
Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska
NCT ID: NCT02012699
Sites in Montana:
  • Bozeman Health Deaconess Hospital — Bozeman, Montana

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-11-09